Kazuya Kuraoka Selected Research

Kazuya Kuraoka Research Topics

Disease

36	Neoplasms (Cancer) 04/2024 - 01/2002
10	Stomach Neoplasms (Stomach Cancer) 10/2023 - 02/2002
9	Neoplasm Metastasis (Metastasis) 04/2023 - 02/2002
9	Breast Neoplasms (Breast Cancer) 02/2023 - 11/2003
9	Carcinoma (Carcinomatosis) 01/2023 - 02/2002
8	Adenocarcinoma 04/2024 - 02/2002
5	Colorectal Neoplasms (Colorectal Cancer) 06/2021 - 11/2017
4	Renal Cell Carcinoma (Grawitz Tumor) 05/2024 - 04/2020
4	Carcinogenesis 10/2005 - 06/2002
3	Lymphatic Metastasis 02/2023 - 04/2004
3	Colonic Neoplasms (Colon Cancer) 01/2023 - 11/2017
2	Brain Neoplasms (Brain Tumor) 04/2023 - 01/2023
2	Infections 03/2023 - 04/2009
2	Disease Progression 02/2023 - 02/2002
2	Hematoma 01/2022 - 12/2020
2	Cavernous Hemangioma (Cavernous Angioma) 01/2022 - 12/2020
2	Hyperplasia 01/2022 - 12/2020
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 04/2021 - 12/2018
2	Rupture 04/2021 - 12/2018
2	Rhabdomyosarcoma 01/2020 - 06/2017
1	Liver Neoplasms (Liver Cancer) 04/2024
1	Rheumatoid Arthritis 01/2024
1	Spontaneous Remission 01/2024
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2024
1	Noninfiltrating Intraductal Carcinoma (DCIS) 12/2023
1	Hodgkin Disease (Hodgkin's Disease) 12/2023
1	Anaplastic Thyroid Carcinoma 04/2023
1	Head and Neck Neoplasms (Head and Neck Cancer) 03/2023
1	Liver Cirrhosis (Hepatic Cirrhosis) 03/2023
1	Osteosarcoma (Osteogenic Sarcoma) 02/2023
1	Cholangiocarcinoma 02/2023
1	Glioblastoma (Glioblastoma Multiforme) 01/2023
1	Primitive Neuroectodermal Tumors (PNET) 01/2023
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2023
1	Pancreatic Neoplasms (Pancreatic Cancer) 11/2022
1	Respiratory Insufficiency (Respiratory Failure) 01/2022
1	Colitis 08/2021
1	Paresthesia (Dysesthesia) 08/2021
1	Fasciculation (Fasciculations) 08/2021
1	Polyradiculoneuropathy (Polyradiculoneuritis) 08/2021
1	Peripheral Nervous System Diseases (PNS Diseases) 08/2021
1	Muscle Weakness 08/2021

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 12/2023 - 02/2002
4	RNA (Ribonucleic Acid)IBA 10/2023 - 02/2002
4	antineoplaston A10 (A 10)IBA 04/2022 - 10/2020
4	Biomarkers (Surrogate Marker)IBA 04/2022 - 05/2004
4	AnnexinsIBA 04/2022 - 10/2020
4	Messenger RNA (mRNA)IBA 01/2022 - 02/2002
3	KinesinsIBA 12/2023 - 01/2023
3	MucinsIBA 10/2023 - 08/2005
3	Keratins (Keratin)IBA 05/2022 - 12/2015
3	Progesterone Receptors (Progesterone Receptor)IBA 01/2022 - 03/2012
3	human ERBB2 proteinIBA 01/2022 - 01/2018
3	Sunitinib (Sutent)FDA Link 10/2021 - 04/2020
3	Imatinib Mesylate (Gleevec)FDA Link 04/2021 - 12/2018
2	Serine Proteases (Serine Protease)IBA 04/2024 - 01/2022
2	Gemcitabine FDA Link 03/2023 - 02/2023
2	Cisplatin (Platino)FDA LinkGeneric 02/2023 - 02/2023
2	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2021
2	VimentinIBA 05/2022 - 12/2015
2	CalponinsIBA 05/2022 - 01/2021
2	Nucleic AcidsIBA 01/2022 - 03/2018
2	Capsules (Microcapsules)IBA 01/2022 - 12/2020
2	AntibodiesIBA 08/2021 - 01/2020
2	pembrolizumabIBA 08/2021 - 07/2021
2	DNA (Deoxyribonucleic Acid)IBA 03/2021 - 01/2002
2	Hormones (Hormone)IBA 10/2019 - 01/2018
2	Estrogen ReceptorsIBA 10/2019 - 03/2012
2	A-factor (Streptomyces)IBA 12/2018 - 06/2018
2	Type II DNA Topoisomerases (Topoisomerase II)IBA 06/2018 - 03/2012
2	NucleotidesIBA 08/2005 - 11/2003
2	alpha2 Subunit Collagen Type IIBA 05/2004 - 04/2004
1	Somatostatin Receptors (Somatostatin Receptor)IBA 05/2024
1	somatostatin receptor 2IBA 05/2024
1	Small Interfering RNA (siRNA)IBA 04/2024
1	Antirheumatic Agents (DMARD)IBA 01/2024
1	tocilizumab (atlizumab)FDA Link 01/2024
1	GTPase-Activating Proteins (GTPase-Activating Protein)IBA 12/2023
1	Gastric MucinsIBA 10/2023
1	lenvatinibIBA 04/2023
1	Tyrosine Kinase InhibitorsIBA 04/2023
1	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2023
1	Bevacizumab (Avastin)FDA Link 01/2023
1	Temozolomide (Temodar)FDA LinkGeneric 01/2023
1	Keratin-19 (Keratin 19)IBA 01/2022
1	AutoantibodiesIBA 08/2021
1	Rheumatoid FactorIBA 08/2021
1	GangliosidesIBA 08/2021
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 08/2021
1	B7-H1 AntigenIBA 07/2021

Therapy/Procedure

9	Therapeutics 01/2024 - 05/2004
7	Drug Therapy (Chemotherapy) 12/2023 - 07/2016
3	Adjuvant Chemotherapy 04/2024 - 04/2021
2	Mastectomy (Mammectomy) 12/2023 - 06/2017
2	Lymph Node Excision (Lymph Node Dissection) 02/2023 - 02/2013
2	Immunotherapy 07/2021 - 01/2021
2	Aftercare (After-Treatment) 03/2019 - 11/2017
2	Radiotherapy 06/2017 - 07/2016
2	Precision Medicine 05/2004 - 06/2002
1	Chemoradiotherapy 01/2023